Bouattour, Y.;                     Neflot-Bissuel, F.;                     Traïkia, M.;                     Biesse-Martin, A.-S.;                     Frederic, R.;                     Yessaad, M.;                     Jouannet, M.;                     Wasiak, M.;                     Chennell, P.;                     Sautou, V.    
        Cyclodextrins Allow the Combination of Incompatible Vancomycin and Ceftazidime into an Ophthalmic Formulation for the Treatment of Bacterial Keratitis. Int. J. Mol. Sci. 2021, 22, 10538.
    https://doi.org/10.3390/ijms221910538
    AMA Style
    
                                Bouattour Y,                                 Neflot-Bissuel F,                                 Traïkia M,                                 Biesse-Martin A-S,                                 Frederic R,                                 Yessaad M,                                 Jouannet M,                                 Wasiak M,                                 Chennell P,                                 Sautou V.        
                Cyclodextrins Allow the Combination of Incompatible Vancomycin and Ceftazidime into an Ophthalmic Formulation for the Treatment of Bacterial Keratitis. International Journal of Molecular Sciences. 2021; 22(19):10538.
        https://doi.org/10.3390/ijms221910538
    
    Chicago/Turabian Style
    
                                Bouattour, Yassine,                                 Florent Neflot-Bissuel,                                 Mounir Traïkia,                                 Anne-Sophie Biesse-Martin,                                 Robin Frederic,                                 Mouloud Yessaad,                                 Mireille Jouannet,                                 Mathieu Wasiak,                                 Philip Chennell,                                 and Valerie Sautou.        
                2021. "Cyclodextrins Allow the Combination of Incompatible Vancomycin and Ceftazidime into an Ophthalmic Formulation for the Treatment of Bacterial Keratitis" International Journal of Molecular Sciences 22, no. 19: 10538.
        https://doi.org/10.3390/ijms221910538
    
    APA Style
    
                                Bouattour, Y.,                                 Neflot-Bissuel, F.,                                 Traïkia, M.,                                 Biesse-Martin, A.-S.,                                 Frederic, R.,                                 Yessaad, M.,                                 Jouannet, M.,                                 Wasiak, M.,                                 Chennell, P.,                                 & Sautou, V.        
        
        (2021). Cyclodextrins Allow the Combination of Incompatible Vancomycin and Ceftazidime into an Ophthalmic Formulation for the Treatment of Bacterial Keratitis. International Journal of Molecular Sciences, 22(19), 10538.
        https://doi.org/10.3390/ijms221910538